|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Ifenprodil>> Market Analysis Reports |
Market Analysis Reports of Ifenprodil |
|
Ifenprodil (CAS 23210-56-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Ifenprodil Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Ifenprodil (CAS 23210-56-2) December 2024 Global Market Report of Ifenprodil tartrate (CAS 23210-58-4) December 2024 CAS 23210-56-2 Ifenprodil Chemical Report & Database ... Report & Database definitions: Name: Ifenprodil: Ifenprodil; 2-(4-Benzylpiperidino)-1-(4-hydroxyphenyl)propanol; 4-[1-Hydroxy-2-[4-(phenylmethyl ... APPLICATIONS: Chemical or Reaction Intermediate The Ifenprodil Report & Database gives Market Consumption ... EC Number: 245-491-4 ifenprodil Chemical Report & Database ... Number: 245-491-4 ifenprodil Chemical Report & Database This ifenprodil Chemical World ... listed. The substance covered (ifenprodil) are classified by the Chemical ... Report & Database definitions: Name: ifenprodil: ifenprodil Chemical Registry number: 769198104146 EC ... NMDA receptor antagonists - Pipeline Insight, 2022 ... Emerging Drugs NP-120 (Ifenprodil): Algernon Pharmaceuticals NP-120 (Ifenprodil) is an N-methyl-d-aspartate ... endoplasmic reticulum stress. NP-120 (Ifenprodil – brand name Cerocal) ... DemeRx Key Products NP-120 (Ifenprodil) REL 1017 Lacosamide ... Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019 Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019'; Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit ... Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 2018 Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 2018 SUMMARY According to the recently published ... Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2022 ... ZSP1603 HEC585 Jaktinib Dihydrochloride Monohydrate Ifenprodil HZN-825 DWN12088 MG-S-2525 Saracatinib ... Influenza A virus H5N1 subtype - Pipeline Insight, 2021 This report can be delivered to the clients within 48 Hours DelveInsight’s, “Influenza A virus H5N1 subtype – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Influenza A virus H5N1 subtype ... Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2022 ... AXS-05 SLS-002 REL-1017 Ifenprodil BHV-5000 AVP-786 OTO ... Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019 Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019 SUMMARY Glutamate Receptor Ionotropic NMDA 2B ( ... Sigma-1 receptor agonists - Pipeline Insight, 2022 This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Sigma-1 receptor agonists - Pipeline Insight, 2022” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Sigma-1 receptor agonists pipeline ... Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cough - Drugs In Development, 2022, provides an overview of the ... Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Drugs In ... |